PerspectivesTargeting the Vascular Endothelium in the Treatment of COVID-19Suvorava, Tatsiana PhD*; Kaesemeyer, Wayne MD†Author Information *Institute of Pharmacology and Clinical Pharmacology, University Hospital, Duesseldorf, Germany; and †Augusta Hypertension PC, Chapel Hill, North Carolina. Reprints: Wayne Kaesemeyer, MD, Augusta Hypertension PC, 108 Tharrington Drive, Chapel Hill, NC 27516-4419 (e-mail: [email protected]). W. Kaesemeyer is an independent researcher. The remaining authors report no conflicts of interest. Journal of Cardiovascular Pharmacology: January 2021 - Volume 77 - Issue 1 - p 1-3 doi: 10.1097/FJC.0000000000000932 Buy Metrics Abstract The involvement of the vascular endothelium in the complications of coronavirus disease 2019 is now recognized. Chief among these are pulmonary endotheliitis, cytokine storm, endotoxic shock, and cardiovascular collapse. This Perspectives article is focused on therapeutical strategies to reduce the risk of these complications by targeting the vascular endothelium as a part of the overall treatment of coronavirus disease 2019. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
